Accrued Expenses and Other Long-Term Liabilities

6 Months Ended

Mar. 31, 2022

Payables And Accruals [Abstract]

Accrued Expenses and Other Long-Term Liabilities

5. Accrued Expenses and Other Long-Term Liabilities

Accrued expenses and other current liabilities, as well as other long-term liabilities, consisted of the following as of March 31, 2022 and September 30, 2021:

	March 31,		September 30,
	2022		2021
	(in thousands)
Accrued expenses:
Accrued pharmaceutical drug manufacturing	$	14,412	$	8,402
Accrued research and development expenses		2,616		6,062
Accrued payroll and related expenses		2,960		6,094
Accrued professional fees		633		700
Accrued other		1,119		1,171
	$	21,740	$	22,429
Other long-term liabilities:
Uncertain tax positions	$	530	$	558
Asset retirement obligation		346		—
	$	876	$	558